Ignite Creation Date:
2024-05-05 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 9:40 AM
Study NCT ID:
NCT00590200
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-18
First Post:
2007-12-26
Brief Title:
GeneBank at the Cleveland Clinic Molecular Determinants of Coronary Artery Disease
Sponsor:
Organization:
The Cleveland Clinic
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Approximately 70 mls of blood will be dispensed as follows Approximately 80 mls if cell lines are drawn or if the patient is having a cardiac CT scan
4 x 10 mls EDTA Tube DNA will be amplified in order to preserve quantity
1 x 10ml Lithium Heparin Tube drawn on selected patient populations at CCF only- See Appendix E for cell line protocol
2 x 5 mls Serum Tube
1 x 7 mls Serum Tube
1 x 27 mls Sodium Citrate Tube CCF Only See Appendix D
1 x 45 mls CTAD tube platelet release inhibited
1 x 45 mls SCAT-1 tube coagulation activation inhibited Blood may be dispensed in the above tubes in different quantities if functional studies are needed on a subset of samples
Enrollment Count:
9880
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Other |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 4579 |
Who Masked List: